BGI Genomics Co., Ltd. (300676.SZ)
CNY 48.27
(1.3%)
CNY 48.27
(1.3%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 602.18 Million CNY | -16.11% |
| 2022 | 717.83 Million CNY | -18.22% |
| 2021 | 877.71 Million CNY | -13.08% |
| 2020 | 1 Billion CNY | 194.43% |
| 2019 | 342.97 Million CNY | 41.78% |
| 2018 | 241.9 Million CNY | 74.56% |
| 2017 | 138.58 Million CNY | 88.31% |
| 2016 | 73.59 Million CNY | -33.94% |
| 2015 | 111.4 Million CNY | 27.96% |
| 2014 | 87.06 Million CNY | 29.19% |
| 2013 | 67.38 Million CNY | 121.05% |
| 2012 | 30.48 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 604.18 Million CNY | 1.81% |
| 2024 Q1 | 593.45 Million CNY | -1.45% |
| 2024 Q3 | 715.33 Million CNY | 18.4% |
| 2023 Q2 | 601.04 Million CNY | -16.01% |
| 2023 Q4 | 602.18 Million CNY | -2.15% |
| 2023 FY | 602.18 Million CNY | -16.11% |
| 2023 Q1 | 715.6 Million CNY | -0.31% |
| 2023 Q3 | 615.4 Million CNY | 2.39% |
| 2022 Q4 | 717.83 Million CNY | -42.37% |
| 2022 Q3 | 1.24 Billion CNY | 22.59% |
| 2022 Q2 | 1.01 Billion CNY | -2.54% |
| 2022 FY | 717.83 Million CNY | -18.22% |
| 2022 Q1 | 1.04 Billion CNY | 18.78% |
| 2021 Q1 | 1.2 Billion CNY | 19.6% |
| 2021 Q4 | 877.71 Million CNY | -16.62% |
| 2021 Q3 | 1.05 Billion CNY | 6.88% |
| 2021 FY | 877.71 Million CNY | -13.08% |
| 2021 Q2 | 984.9 Million CNY | -18.45% |
| 2020 Q4 | 1 Billion CNY | -9.02% |
| 2020 FY | 1 Billion CNY | 194.43% |
| 2020 Q1 | 616.78 Million CNY | 79.83% |
| 2020 Q2 | 1.27 Billion CNY | 107.02% |
| 2020 Q3 | 1.1 Billion CNY | -13.07% |
| 2019 Q4 | 342.97 Million CNY | -5.5% |
| 2019 FY | 342.97 Million CNY | 41.78% |
| 2019 Q3 | 362.92 Million CNY | 26.35% |
| 2019 Q2 | 287.23 Million CNY | 19.2% |
| 2019 Q1 | 240.96 Million CNY | -0.39% |
| 2018 Q4 | 241.9 Million CNY | 17.7% |
| 2018 Q1 | 149.36 Million CNY | 7.78% |
| 2018 Q2 | 178.36 Million CNY | 19.41% |
| 2018 FY | 241.9 Million CNY | 74.56% |
| 2018 Q3 | 205.53 Million CNY | 15.23% |
| 2017 FY | 138.58 Million CNY | 88.31% |
| 2017 Q3 | 133.67 Million CNY | 3.56% |
| 2017 Q1 | 95.38 Million CNY | 29.6% |
| 2017 Q2 | 129.08 Million CNY | 35.34% |
| 2017 Q4 | 138.58 Million CNY | 3.67% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q4 | 73.59 Million CNY | 0.0% |
| 2016 FY | 73.59 Million CNY | -33.94% |
| 2015 Q2 | 94.41 Million CNY | 0.0% |
| 2015 Q4 | 111.4 Million CNY | 0.0% |
| 2015 FY | 111.4 Million CNY | 27.96% |
| 2015 Q1 | 94.41 Million CNY | 0.0% |
| 2014 FY | 87.06 Million CNY | 29.19% |
| 2013 FY | 67.38 Million CNY | 121.05% |
| 2012 FY | 30.48 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 1.5 Billion CNY | 60.093% |
| Hangzhou Tigermed Consulting Co., Ltd. | 23.39 Million CNY | -2473.684% |
| Dirui Industrial Co.,Ltd. | 572.93 Million CNY | -5.105% |
| Beijing Strong Biotechnologies, Inc. | 229.74 Million CNY | -162.109% |
| Medicalsystem Biotechnology Co., Ltd. | 259.01 Million CNY | -132.494% |
| Maccura Biotechnology Co.Ltd | 907.48 Million CNY | 33.643% |
| Guangzhou Wondfo Biotech Co.,Ltd | 351.4 Million CNY | -71.366% |
| Guangdong Hybribio Biotech Co.,Ltd. | 99.55 Million CNY | -504.856% |
| Amoy Diagnostics Co., Ltd. | 28.78 Million CNY | -1992.171% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 367.71 Million CNY | -63.765% |